The cervical screening programme hers hard a dramatic impact on the inciden
ce of invasive cervical cancer and preinvasive disease can be effectively t
reated in the majority of cases, However, recurrent abnormalities after tre
atment pose management dilemmas which are considered in this overview of th
e topic.